M&A Deal Summary

St. Jude Medical Acquires Advanced Neuromodulation Systems

On October 17, 2005, St. Jude Medical acquired medical products company Advanced Neuromodulation Systems for 1.3B USD

Acquisition Highlights
  • This is St. Jude Medical’s 7th transaction in the Medical Products sector.
  • This is St. Jude Medical’s 3rd largest (disclosed) transaction.
  • This is St. Jude Medical’s 6th transaction in the United States.
  • This is St. Jude Medical’s 1st transaction in Texas.

M&A Deal Summary
Date 2005-10-17
Target Advanced Neuromodulation Systems
Sector Medical Products
Buyer(s) St. Jude Medical
Deal Type Add-on Acquisition
Deal Value 1.3B USD
Advisor(s) Baker Botts (Legal)

Target

Advanced Neuromodulation Systems

Plano, Texas, United States
Advanced Neuromodulation Systems, Inc. designs, develops, manufactures and markets implantable systems used to manage chronic intractable pain and other disorders of the central nervous system.

Search 193,605 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

St. Jude Medical

Saint Paul, Minnesota, United States

website

Category Company
Founded 1976
Sector Medical Products
Employees18,000
Revenue 5.5B USD (2016)
DESCRIPTION
Entrance to St. Jude Medical's corporate headquarters in St. Paul, Minnesota.
Entrance to St. Jude Medical's corporate headquarters in St. Paul, Minnesota.

St. Jude Medical, Inc. is a medical device manufacturer dedicated to transforming the treatment of most expensive, epidemic diseases. St. Jude Medical five major areas of focus that include heart failure, atrial fibrillation, neuromodulation, traditional cardiac rhythm management and cardiovascular. St. Jude Medical was formed in 1976 and is based in St. Paul, Minnesota.

DEAL STATS #
Overall 7 of 18
Sector (Medical Products) 7 of 17
Type (Add-on Acquisition) 7 of 17
State (Texas) 1 of 1
Country (United States) 6 of 15
Year (2005) 3 of 3
Size (of disclosed) 3 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-02-15 Velocimed

Maple Grove, Minnesota, United States

Velocimed, Inc. is a private company focused on the development of three novel cardiovascular devices.

Buy $74M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-01-03 Savacor

Los Angeles, California, United States

Savacor has heart failure diagnostic and therapy guidance products and technologies under development and in clinical evaluation, including a small implantable sensor device in clinical trials that helps physicians detect and manage symptoms associated with progressive heart failure.

Buy -
Mergr

Product

Company

Legal